These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8431359)

  • 1. A recombinant single chain antibody interleukin-2 fusion protein.
    Savage P; So A; Spooner RA; Epenetos AA
    Br J Cancer; 1993 Feb; 67(2):304-10. PubMed ID: 8431359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant single-chain antibody interleukin-2 fusion protein.
    Savage P; So A; Spooner RA; Epenetos AA
    Cell Biophys; 1993; 22(1-3):61-77. PubMed ID: 7889543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-chain antibody variable region-targeted interleukin-2 stimulates T cell killing of human colorectal carcinoma cells.
    Xiang J; Liu E; Moyana T; Qi Y
    Immunol Cell Biol; 1994 Aug; 72(4):275-85. PubMed ID: 7806260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
    Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
    Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin.
    Chaudhary VK; Queen C; Junghans RP; Waldmann TA; FitzGerald DJ; Pastan I
    Nature; 1989 Jun; 339(6223):394-7. PubMed ID: 2498664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and in vitro and in vivo anti-tumor response of an interleukin-2-human serum albumin fusion protein in mice.
    Melder RJ; Osborn BL; Riccobene T; Kanakaraj P; Wei P; Chen G; Stolow D; Halpern WG; Migone TS; Wang Q; Grzegorzewski KJ; Gallant G
    Cancer Immunol Immunother; 2005 Jun; 54(6):535-47. PubMed ID: 15592670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human interleukin-2-IgM heavy-chain-fusion proteins are cytotoxic for cells expressing the IL2 receptor.
    Vie H; Gauthier T; Breathnach R; Bonneville M; Godard A; Dietrich J; Karam G; Gesnel MC; Peyrat MA; Jacques Y
    Transplant Proc; 1993 Feb; 25(1 Pt 1):741-2. PubMed ID: 8438463
    [No Abstract]   [Full Text] [Related]  

  • 8. Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines.
    Wagner B; Robeson J; McCracken M; Wattrang E; Antczak DF
    Vet Immunol Immunopathol; 2005 May; 105(1-2):1-14. PubMed ID: 15797470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of human effector cells by a tumor reactive recombinant anti-ganglioside GD2 interleukin-2 fusion protein (ch14.18-IL2).
    Hank JA; Surfus JE; Gan J; Jaeger P; Gillies SD; Reisfeld RA; Sondel PM
    Clin Cancer Res; 1996 Dec; 2(12):1951-9. PubMed ID: 9816154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of low-toxicity interleukin-2 fusion proteins devoid of vasopermeability activity.
    Hu P; Mizokami M; Ruoff G; Khawli LA; Epstein AL
    Blood; 2003 Jun; 101(12):4853-61. PubMed ID: 12609842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibody.
    Melani C; Figini M; Nicosia D; Luison E; Ramakrishna V; Casorati G; Parmiani G; Eshhar Z; Canevari S; Colombo MP
    Cancer Res; 1998 Sep; 58(18):4146-54. PubMed ID: 9751627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bifunctional hybrids between the variable domains of an immunoglobulin and the maltose-binding protein of Escherichia coli: production, purification and antigen binding.
    Brégégère F; Schwartz J; Bedouelle H
    Protein Eng; 1994 Feb; 7(2):271-80. PubMed ID: 8170930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant IL 2 but not recombinant interferon-gamma stimulates both proliferation and IgM secretion in a Ly-1+ clone of neoplastic murine B cells (BCL1).
    Brooks KH; Vitetta ES
    J Immunol; 1986 Nov; 137(10):3205-10. PubMed ID: 2945863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors.
    Eshhar Z; Waks T; Gross G; Schindler DG
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):720-4. PubMed ID: 8421711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and characterization of a novel fusion protein consisting of anti-CD3 antibody fused to recombinant interleukin-2.
    Lee KD; Chen HW; Chen CC; Shih YC; Liu HK; Cheng ML
    Oncol Rep; 2006 May; 15(5):1211-6. PubMed ID: 16596189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential effects of interleukin 2-diphtheria toxin fusion protein on T-cell activation.
    Walz G; Zanker B; Brand K; Waters C; Genbauffe F; Zeldis JB; Murphy JR; Strom TB
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9485-8. PubMed ID: 2594781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new recombinant single chain trispecific antibody recruits T lymphocytes to kill CEA (carcinoma embryonic antigen) positive tumor cells in vitro efficiently.
    Wang XB; Zhao BF; Zhao Q; Piao JH; Liu J; Lin Q; Huang HL
    J Biochem; 2004 Apr; 135(4):555-65. PubMed ID: 15115782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recombinant, membrane-acting immunotoxin.
    Chovnick A; Schneider WP; Tso JY; Queen C; Chang CN
    Cancer Res; 1991 Jan; 51(2):465-7. PubMed ID: 1898711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-mediated targeting of human single-chain class I MHC with covalently linked peptides induces efficient killing of tumor cells by tumor or viral-specific cytotoxic T lymphocytes.
    Oved K; Lev A; Noy R; Segal D; Reiter Y
    Cancer Immunol Immunother; 2005 Sep; 54(9):867-79. PubMed ID: 15906027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of a murine and chimeric mouse/human anti-interleukin-2 receptor antibody on human T-cell proliferation.
    Rose B; Gillespie A; Wunderlich D; Kelley K; Dzuiba J; Shedd D; Cahill K; Zerler B
    Immunology; 1992 Jul; 76(3):452-9. PubMed ID: 1526654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.